The DOI matches its Crossref record; 45 of the 46 references it cites were found in a registry or an index.
Cholinergic signaling in the hippocampus regulates social stress resilience and anxiety- and depression-like behavior
Open accessAbstract
Symptoms of depression can be induced in humans through blockade of acetylcholinesterase (AChE) whereas antidepressant-like effects can be produced in animal models and some clinical trials by limiting activity of acetylcholine (ACh) receptors. Thus, ACh signaling could contribute to the etiology of mood regulation. To test this hypothesis, we administered the AChE inhibitor physostigmine to mice and demonstrated an increase in anxiety- and depression-like behaviors that was reversed by administration of nicotinic or muscarinic antagonists. The behavioral effects of physostigmine were also reversed by administration of the selective serotonin reuptake inhibitor fluoxetine. Administration of fluoxetine also increased AChE activity throughout the brain, with the greatest change in the hippocampus. To determine whether cholinergic signaling in the hippocampus could contribute to the systemic effects of cholinergic drugs, we infused physostigmine or virally delivered shRNAs targeting AChE into the hippocampus. Both pharmacological and molecular genetic decreases in hippocampal AChE activity increased anxiety- and depression-like behaviors and decreased resilience to repeated stress in a social defeat paradigm. The behavioral changes due to shRNA-mediated knockdown of AChE were rescued by coinfusion of an shRNA-resistant AChE transgene into the hippocampus and reversed by systemic administration of fluoxetine. These data demonstrate that ACh signaling in the hippocampus promotes behaviors related to anxiety and depression. The sensitivity of these effects to fluoxetine suggests that shRNA-mediated knockdown of hippocampal AChE represents a model for anxiety- and depression-like phenotypes. Furthermore, abnormalities in the cholinergic system may be critical for the etiology of mood disorders and could represent an endophenotype of depression.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The cited source says what the claim attributes to it.
In the citing paper
“Increasing acetylcholine signaling in the hippocampus via local knockdown of acetylcholine esterase (AChE) results in increased avoidance of anxiogenic environments, in-creased immobility in response to inescapable stress, and decreased threshold for social defeat (Mineur et al. 2013).”
From Mechanisms of Nicotine Addiction (2021) · cites this paper as Mineur et al. 2013
In the citing paper
“while increased ACh transmission can increase behaviors related to depression in humans (Risch et al., 1980) and rodents (Mineur et al., 2013), the type of circuits/cell types that are modulated by ACh or nAChRs can have opposite effects on mood regulation, and the outcome on behavior depends on the sum of these effects.”
From Mood and anxiety regulation by nicotinic acetylcholine receptors: A potential pathway to modulate aggression and related behavioral states (2015) · cites this paper as Mineur et al., 2013
In the citing paper
“These results indicate that abnormal nicotinic signaling may underlie depression symptoms (Mineur et al., 2013; Tizabi et al., 2000)”
From Mood and anxiety regulation by nicotinic acetylcholine receptors: A potential pathway to modulate aggression and related behavioral states (2015) · cites this paper as Mineur et al., 2013
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Influence of life stress on depression: moderation by a polymorphism in the 5-HTT gene
Caspi, A., Sugden, K., Moffitt, T. E., Taylor, A., Craig, I. W., Harrington, H., McClay, J., Mill, J., Martin, J., Braithwaite, A., et al. (2003) · Science · doi:10.1126/science.1083968 · Cited by 8,120
A "DIRECT-COLORING" THIOCHOLINE METHOD FOR CHOLINESTERASES
Karnovsky, M. J., & ROOTS, L. (1964) · Journal of Histochemistry & Cytochemistry · doi:10.1177/12.3.219 · Cited by 3,368
Krishnan, V., Han, M.-H., Graham, D. L., Berton, O., Renthal, W., Russo, S. J., LaPlant, Q., Graham, A., Lutter, M., Lagace, D. C., et al. (2007) · Cell · doi:10.1016/j.cell.2007.09.018 · Cited by 2,307 · cited 1×
“To test whether manipulations of AChE could potentiate an animal’s susceptibility to psychosocial stress induced by repeated defeat, we also used the submaximal defeat paradigm as reported previously (43).”
MethodEssential role of BDNF in the mesolimbic dopamine pathway in social defeat stress
Berton, O., McClung, C. A., DiLeone, R. J., Krishnan, V., Renthal, W., Russo, S. J., Graham, D., Tsankova, N. M., Bolanos, C. A., Rios, M., et al. (2006) · Science · doi:10.1126/science.1120972 · Cited by 2,129
Cryan, J. F., Mombereau, C., & Vassout, A. (2005) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2005.03.009 · Cited by 1,674
Acetylcholinesterase — new roles for an old actor
Soreq, H., & Seidman, S. (2001) · Nature reviews. Neuroscience · doi:10.1038/35067589 · Cited by 1,437
Acetylcholine as a Neuromodulator: Cholinergic Signaling Shapes Nervous System Function and Behavior
Picciotto, M. R., Higley, M. J., & Mineur, Y. S. (2012) · Neuron · doi:10.1016/j.neuron.2012.08.036 · Cited by 1,404
Self-citationA cholinergic-adrenergic hypothesis of mania and depression
Janowsky, D., Davis, J., El-Yousef, M. K., & Sekerke, H. J. (1972) · The Lancet · doi:10.1016/s0140-6736(72)93021-8 · Cited by 1,134
Linking Molecules to Mood: New Insight Into the Biology of Depression
Krishnan, V., & Nestler, E. J. (2010) · American Journal of Psychiatry · doi:10.1176/appi.ajp.2009.10030434 · Cited by 666
Acute stress facilitates long-lasting changes in cholinergic gene expression
Kaufer, D., Friedman, A., Seidman, S., & Soreq, H. (1998) · Nature · doi:10.1038/30741 · Cited by 588
Research works printed but not linked: 1
- 10.1037/0735-7044.112.2.352 · DOI
Cited by
Sorted by citations
Items 101–200 of 374
Kim, J. H., Sohn, U. D., Kim, H., & Kim, H. R. (2018) · Korean Journal of Physiology and Pharmacology · doi:10.4196/kjpp.2018.22.3.277 · Cited by 39
Anesti, M., Stavropoulou, N. A., Atsopardi, Κ., Lamari, F. N., Panagopoulos, N. T., & Margarity, M. (2019) · Epilepsy & Behavior · doi:10.1016/j.yebeh.2019.106632 · Cited by 38
Mitić, M., & Pašti, T. D. L. (2021) · Expert Opinion on Drug Metabolism & Toxicology · doi:10.1080/17425255.2021.1931681 · Cited by 39
Malki, K., Mineur, Y. S., Tosto, M. G., Campbell, J., Karia, P., Jumabhoy, I., Sluyter, F., Crusio, W. E., & Schalkwyk, L. C. (2015) · BMC Genomics · doi:10.1186/s12864-015-1431-6 · Cited by 40
Self-citationSuarez-Lopez, J. R., Nguyen, A., Klas, J., Gahagan, S., Checkoway, H., López-Paredes, D., Jacobs, D. R., & Noble, M. L. (2020) · Exposure and Health · doi:10.1007/s12403-020-00361-w · Cited by 37
Ishola, I. O., Ben‐Azu, B., Adebayo, O. A., Ajayi, A. M., Omorodion, I. L., Edje, K. E., & Adeyemi, O. O. (2021) · Brain Research Bulletin · doi:10.1016/j.brainresbull.2021.10.007 · Cited by 38
Mineur, Y. S., Mose, T. N., Maibom, K. L., Pittenger, S. T., Soares, A. R., Wu, H., Taylor, S. R., Huang, Y., & Picciotto, M. R. (2022) · Molecular Psychiatry · doi:10.1038/s41380-022-01749-7 · Cited by 36
Self-citationIto, N., Hirose, E., Ishida, T., Hori, A., Nagai, T., Kobayashi, Y., Kiyohara, H., Oikawa, T., Hanawa, T., & Odaguchi, H. (2017) · Journal of Neuroinflammation · doi:10.1186/s12974-017-0876-8 · Cited by 36
Kim, Y. R., Park, B.-K., Kim, Y. H., Shim, I., Kang, I., & Lee, M. Y. (2018) · BioMed Research International · doi:10.1155/2018/8249563 · Cited by 37
Fitzgerald, P. J., Hale, P. J., Ghimire, A., & Watson, B. O. (2020) · Translational Psychiatry · doi:10.1038/s41398-020-00928-w · Cited by 35
Immune status influences fear and anxiety responses in mice after acute stress exposure
Clark, S. M., Sand, J., Francis, T. C., Nagaraju, A., Michael, K. C., Keegan, A. D., Kusnecov, A. W., Gould, T. D., & Tonelli, L. H. (2014) · Brain Behavior and Immunity · doi:10.1016/j.bbi.2014.02.001 · Cited by 33
AChE and RACK1 Promote the Anti-Inflammatory Properties of Fluoxetine
Waiskopf, N., Ofek, K., Gilboa-Geffen, A., Bekenstein, U., Bahat, A., Bennett, E. R., Podoly, E., Livnah, O., Hartmann, G., & Soreq, H. (2013) · Journal of Molecular Neuroscience · doi:10.1007/s12031-013-0174-6 · Cited by 34
Two-Photon Fluorescent Probes for Detecting Enzyme Activities in Live Tissues
Juvekar, V., Lee, H. W., & Kim, H. M. (2021) · ACS Applied Bio Materials · doi:10.1021/acsabm.1c00063 · Cited by 34
Tse, Y. C., Lopez, J., Moquin, A., Wong, S.-M. A., Maysinger, D., & Wong, T. P. (2019) · Neuropsychopharmacology · doi:10.1038/s41386-019-0325-8 · Cited by 32
Yusishen, M. E., Yoon, G. R., Bugg, W. S., Jeffries, K. M., Currie, S., & Anderson, W. G. (2020) · Comparative Biochemistry and Physiology Part A Molecular & Integrative Physiology · doi:10.1016/j.cbpa.2020.110686 · Cited by 31
Furqan, T., Batool, S., Habib, R., Shah, M., Kalász, H., Darvas, F., Kuča, K., Nepovimová, E., Batool, S., & Nurulain, S. M. (2020) · Biomolecules · doi:10.3390/biom10050758 · Cited by 35
Atrazine neural and reproductive toxicity
Sadeghnia, H. R., Shahba, S., Ebrahimzadeh‐Bideskan, A., Mohammadi, S., Malvandi, A. M., & Mohammadipour, A. (2021) · Toxin Reviews · doi:10.1080/15569543.2021.1966637 · Cited by 33
Mineur, Y. S., Einstein, E. B., Bentham, M. P., Wigestrand, M. B., Blakeman, S., Newbold, S. A., & Picciotto, M. R. (2014) · Neuropsychopharmacology · doi:10.1038/npp.2014.269 · Cited by 34
Self-citationChemical anatomy of pallidal afferents in primates
Eid, L., & Parent, M. (2016) · Brain Structure and Function · doi:10.1007/s00429-016-1216-y · Cited by 33
Mei, L., Zhou, Y., Sun, Y., Liu, H. S., Zhang, D., Liu, P., & Shu, H. (2020) · Frontiers in Molecular Neuroscience · doi:10.3389/fnmol.2020.598811 · Cited by 32
Behavioral disorders caused by nonylphenol and strategies for protection
Lu, D., Yu, L., Li, M., Zhai, Q., Tian, F., & Chen, W. (2021) · Chemosphere · doi:10.1016/j.chemosphere.2021.129973 · Cited by 33
Maturana, M. J., Pudell, C., Targa, A., Rodrigues, L. S., Noseda, A. C. D., Fortes, M. H., Santos, P. C. D., Cunha, C. D., Zanata, S. M., Ferraz, A. C., et al. (2014) · Molecular Neurobiology · doi:10.1007/s12035-014-8721-x · Cited by 31
Potasiewicz, A., Krawczyk, M., Gzieło, K., Popik, P., & Nikiforuk, A. (2020) · Behavioural Brain Research · doi:10.1016/j.bbr.2020.112547 · Cited by 31
Wang, X., Yu, H. Q., Wang, C., Liu, Y., You, J., Wang, P., Xu, G., Shen, H., Yao, H., Lan, X., et al. (2020) · Toxicology · doi:10.1016/j.tox.2020.152625 · Cited by 31
Neurochemical and Behavioral Effects of a New Hallucinogenic Compound 25B-NBOMe in Rats
Wojtas, A., Herian, M., Skawski, M., Sobocińska, M. K., González-Marín, A., Noworyta, K., & Gołembiowska, K. (2020) · Neurotoxicity Research · doi:10.1007/s12640-020-00297-8 · Cited by 29
Mineur, Y. S., Bentham, M. P., Zhou, W., Plantenga, M. E., McKee, S. A., & Picciotto, M. R. (2015) · Psychopharmacology · doi:10.1007/s00213-015-4001-3 · Cited by 31
Self-citationThe Hippocampus and Social Impairment in Psychiatric DisordersPreprint
Schafer, M., & Schiller, D. (2018) · Cold Spring Harbor Symposia on Quantitative Biology · doi:10.1101/sqb.2018.83.037614 · Cited by 31
Nanoplastics as Gene and Epigenetic Modulators of Endocrine Functions: A Perspective
Aloisi, M., & Poma, A. M. G. (2025) · International Journal of Molecular Sciences · doi:10.3390/ijms26052071 · Cited by 31
Cholinergic system in schizophrenia: A systematic review and meta-analysis
Saint-Georges, Z., MacDonald, J., Al-Khalili, R., Hamati, R., Solmi, M., Keshavan, M. S., Tuominen, L. J., & Guimond, S. (2025) · Molecular Psychiatry · doi:10.1038/s41380-025-03023-y · Cited by 32
Fear circuit–based neurobehavioral signatures mirror resilience to chronic social stress in mouse
Ayash, S., Lingner, T., Ramisch, A., Ryu, S., Kalisch, R., Schmitt, U., & Müller, M. B. (2023) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2205576120 · Cited by 31
Putative role of monoamines in the antidepressant-like mechanism induced by striatal MT2 blockade
Noseda, A. C. D., Rodrigues, L. S., Targa, A., Aurich, M. F., Vital, M. A. B. F., Cunha, C. D., & Lima, M. M. S. (2014) · Behavioural Brain Research · doi:10.1016/j.bbr.2014.09.007 · Cited by 28
Bhagya, V., Srikumar, B. N., Raju, T., & Rao, S. (2015) · Journal of Neuroscience Research · doi:10.1002/jnr.23473 · Cited by 28
Fitzgerald, P. J., Hale, P. J., Ghimire, A., & Watson, B. O. (2021) · Frontiers in Behavioral Neuroscience · doi:10.3389/fnbeh.2020.620119 · Cited by 28
Arias, H. R., Targowska‐Duda, K. M., García‐Colunga, J., & Ortells, M. O. (2021) · Molecules · doi:10.3390/molecules26082149 · Cited by 30
Qi, Y., Wang, H., Chen, L., Guo, L., Cao, Y., Yang, Y., Duan, Y., & Zhu, H. (2021) · Coordination Chemistry Reviews · doi:10.1016/j.ccr.2021.214068 · Cited by 27
Ameliorative effects of probiotics in AlCl3-induced mouse model of Alzheimer’s disease
Hamid, M., & Zahid, S. (2023) · Applied Microbiology and Biotechnology · doi:10.1007/s00253-023-12686-y · Cited by 26
Mazuryk, J., Klepacka, K., Kutner, W., & Sharma, P. S. (2024) · Ecotoxicology and Environmental Safety · doi:10.1016/j.ecoenv.2024.115965 · Cited by 27
Protective Effect of Galantamine against Doxorubicin-Induced Neurotoxicity
Alsikhan, R. S., Aldubayan, M. A., Almami, I. S., & Alhowail, A. H. (2023) · Brain Sciences · doi:10.3390/brainsci13060971 · Cited by 27
Anticholinergic Activity and Schizophrenia
Tani, M., Akashi, N., Hori, K., Konishi, K., Kitajima, Y., Tomioka, H., Inamoto, A., Hirata, A., Tomita, A., Koganemaru, T., et al. (2015) · Neurodegenerative Diseases · doi:10.1159/000381523 · Cited by 26
Nakajima, K., Miranda, A. H., Craig, D. W., Shekhtman, T., Kmoch, S., Bleyer, A. J., Szelinger, S., Kato, T., & Kelsoe, J. R. (2020) · Translational Psychiatry · doi:10.1038/s41398-020-01087-8 · Cited by 24
Methyl-CpG binding domain 2 (Mbd2) is an epigenetic regulator of autism-risk genes and cognition
Lax, E., Carmo, S. D., Enuka, Y., Sapozhnikov, D. M., Welikovitch, L. A., Mahmood, N., Rabbani, S. A., Wang, L., Britt, J. P., Hancock, W. W., et al. (2023) · Translational Psychiatry · doi:10.1038/s41398-023-02561-9 · Cited by 25
Hayase, T. (2016) · PLoS ONE · doi:10.1371/journal.pone.0158950 · Cited by 25
Acute exposure to leucine modifies behavioral parameters and cholinergic activity in zebrafish
Wessler, L. B., Farias, H. R., Ronsani, J. F., Candiotto, G., dos Santos, P. C. L., de Oliveira, J., Rico, E. P., & STRECK, E. L. (2019) · International Journal of Developmental Neuroscience · doi:10.1016/j.ijdevneu.2019.10.001 · Cited by 25
Calarco, C. A., Li, Z., Taylor, S. R., Lee, S., Zhou, W., Friedman, J. M., Mineur, Y. S., Gotti, C., & Picciotto, M. R. (2018) · European Journal of Neuroscience · doi:10.1111/ejn.13966 · Cited by 24
Self-citationAbdel-Rasoul, A. A., Saleh, N. A., Hosny, E. N., El-Gizawy, M. M., & Ibrahim, E. A. (2023) · Journal of Ethnopharmacology · doi:10.1016/j.jep.2023.116254 · Cited by 24
Nosjean, A., Cressant, A., de Chaumont, F., Olivo‐Marín, J., Chauveau, F., & Granon, S. (2015) · Frontiers in Behavioral Neuroscience · doi:10.3389/fnbeh.2014.00447 · Cited by 26
Hasegawa, S., Miyake, Y., Yoshimi, A., Mouri, A., Hida, H., Yamada, K., Ozaki, N., Nabeshima, T., & Noda, Y. (2018) · The International Journal of Neuropsychopharmacology · doi:10.1093/ijnp/pyy038 · Cited by 26
Nunes, E. J., Bitner, L. E., Hughley, S. M., Small, K. M., Walton, S. N., Rupprecht, L. E., & Addy, N. (2019) · Neuroscience · doi:10.1016/j.neuroscience.2019.06.028 · Cited by 25
Zhang, L., Wu, C., Martel, D. T., West, M., Sutton, M. A., & Shore, S. E. (2021) · Neural Plasticity · doi:10.1155/2021/8833087 · Cited by 25
Converged avenues: depression and Alzheimer’s disease– shared pathophysiology and novel therapeutics
Bajaj, S., & Mahesh, R. (2024) · Molecular Biology Reports · doi:10.1007/s11033-023-09170-1 · Cited by 25
Enhanced cholinergic-tone during the stress induce a depressive-like state in mice
Fernandes, S. S., Koth, A. P., Parfitt, G. M., Cordeiro, M. F., Peixoto, C. S., Soubhia, A., Moreira, F. P., Wiener, C. D., Oses, J. P., Kaszubowski, E., et al. (2018) · Behavioural Brain Research · doi:10.1016/j.bbr.2018.02.044 · Cited by 26
Zhang, S., Hu, S., Dong, W., Huang, S., Jiao, Z., Hu, Z., Dai, S., Yi, Y., Gong, X., Li, K., et al. (2021) · Cell Biology and Toxicology · doi:10.1007/s10565-021-09621-0 · Cited by 23
Neonatal allopregnanolone levels alteration: Effects on behavior and role of the hippocampus
Darbra, S., Mòdol, L., Llidó, A., Casas, C., Vallée, M., & Pallarés, M. (2013) · Progress in Neurobiology · doi:10.1016/j.pneurobio.2013.07.007 · Cited by 23
Mohammadi, S. A., Burton, T. J., & Christie, M. J. (2017) · Behavioural Brain Research · doi:10.1016/j.bbr.2017.04.005 · Cited by 23
Duan, G., Liu, H., Pang, Y., Liu, P., Liu, Y., Wang, G., Liao, H., Tang, L., Chen, W., Mo, X., et al. (2017) · Journal of Magnetic Resonance Imaging · doi:10.1002/jmri.25775 · Cited by 23
Cholinergic transmission from the basal forebrain modulates social memory in male mice
Kljakic, O., Al‐Onaizi, M., Janíčková, H., Chen, K. S., Guzman, M. S., Prado, M. A. M., & Prado, V. F. (2021) · European Journal of Neuroscience · doi:10.1111/ejn.15400 · Cited by 22
Wolugbom, J. A., Areloegbe, S. E. J., & Olaniyi, K. S. (2022) · Molecular Neurobiology · doi:10.1007/s12035-022-03074-0 · Cited by 25
Marszalek-Grabska, M., Gibula-Bruzda, E., Jenda, M., Gawel, K., & Kotlinska, J. H. (2016) · Brain Research · doi:10.1016/j.brainres.2016.04.026 · Cited by 22
Intensified vmPFC surveillance over PTSS under perturbed microRNA-608/AChE interaction
Lin, T., Simchovitz, A., Shenhar‐Tsarfaty, S., Vaisvaser, S., Admon, R., Hanin, G., Hanan, M., Kliper, E., Bar‐Haim, Y., Shomron, N., et al. (2016) · Translational Psychiatry · doi:10.1038/tp.2016.70 · Cited by 22
Neves, G. A., & Grace, A. A. (2019) · European Neuropsychopharmacology · doi:10.1016/j.euroneuro.2019.09.009 · Cited by 22
de Sousa, C. N. S., Meneses, L. N., Vasconcelos, G. S., Medeiros, I. D. S., Silva, M. C. C., Mouaffak, F., Kébir, O., Leite, C. M. G. D. S., Patrocínio, M. C. A., Macêdo, D. S., et al. (2018) · Naunyn-Schmiedeberg s Archives of Pharmacology · doi:10.1007/s00210-018-1509-1 · Cited by 22
Phosphodiesterase-5 inhibitors: Shedding new light on the darkness of depression?
Duarte-Silva, E. P., Filho, A. J. M. C., Barichello, T., Quevedo, J., Macêdo, D. S., & Peixoto, C. A. (2019) · Journal of Affective Disorders · doi:10.1016/j.jad.2019.11.114 · Cited by 20
Yeni, Y., Çakır, Z. G., Hacımüftüoğlu, A., Taghizadehghalehjoughi, A., Okkay, U., Genç, S., Yıldırım, S., Sağlam, Y. S., Călina, D. C., Tsatsakis, A. M., et al. (2022) · Journal of Personalized Medicine · doi:10.3390/jpm12020246 · Cited by 21
Gottschalk, M. G., Mortas, P., Haman, M., Özcan, S., Biemans, B., & Bahn, S. (2017) · European Neuropsychopharmacology · doi:10.1016/j.euroneuro.2017.11.002 · Cited by 21
Altered brain structure in women with premenstrual syndrome
Liu, P., Wei, Y., Fan, Y., Li, R., Liu, Y., Wang, G., Wei, Y., Pang, Y., Deng, D., & Qin, W. (2018) · Journal of Affective Disorders · doi:10.1016/j.jad.2017.12.075 · Cited by 22
Nicotine Self-Administration Induces Plastic Changes to Nicotinic Receptors in Medial Habenula
Jin, X., Tucker, B. R., & Drenan, R. M. (2020) · eNeuro · doi:10.1523/eneuro.0197-20.2020 · Cited by 23
Carotenuto, A., Fasanaro, A. M., Manzo, V., Amenta, F., & Traini, E. (2022) · Journal of Alzheimer s Disease Reports · doi:10.3233/adr-200269 · Cited by 20
Transport mechanism of presynaptic high-affinity choline uptake by CHT1
Qiu, Y., Gao, Y., Huang, B., Bai, Q., & Zhao, Y. (2024) · Nature Structural & Molecular Biology · doi:10.1038/s41594-024-01259-w · Cited by 20
Artigas, F., Celada, P., & Bortolozzi, A. A. (2018) · European Neuropsychopharmacology · doi:10.1016/j.euroneuro.2018.01.005 · Cited by 20
Food Components with the Potential to be Used in the Therapeutic Approach of Mental Diseases
Fernández, M. J. F., Valero‐Cases, E., & Frutos‐Rincón, L. (2018) · Current Pharmaceutical Biotechnology · doi:10.2174/1389201019666180925120657 · Cited by 20
de Abreu, M. S., Giacomini, A. C. V. V., dos Santos, B. E., Genário, R., Marchiori, N. I., da Rosa, L. G., & Kalueff, A. V. (2018) · Neuroscience Letters · doi:10.1016/j.neulet.2018.11.004 · Cited by 20
Umukoro, S., Ben‐Azu, B., Ajayi, A. M., Adebesin, A., & Emokpae, O. (2020) · Chinese Herbal Medicines · doi:10.1016/j.chmed.2020.01.002 · Cited by 20
7-phenoxytacrine is a dually acting drug with neuroprotective efficacy in vivo
Kaniaková, M., Korábečný, J., Holubová, K., Kletečková, L., Chvojková, M., Hakenova, K., Prchal, L., Novak, M., Doležal, R., Hepnarová, V., et al. (2021) · Biochemical Pharmacology · doi:10.1016/j.bcp.2021.114460 · Cited by 17
Chen, L., Ke, Y., Ma, H., Gao, L., Zhou, Y., Zhu, H., Liu, H., Zhang, F., & Zhou, W. (2021) · Frontiers in Behavioral Neuroscience · doi:10.3389/fnbeh.2021.602708 · Cited by 18
Jangra, A., Chadha, V., Kumar, D., Kumar, V., & Arora, M. K. (2021) · Current Research in Behavioral Sciences · doi:10.1016/j.crbeha.2021.100060 · Cited by 21
Xie, Z., Lu, G., & Yu, Y. (2022) · International Journal of Environmental Research and Public Health · doi:10.3390/ijerph191710920 · Cited by 19
Zhou, G., Wang, X., Gao, P., Qin, T., Guo, L. T., Zhang, Z., Huang, Z., Lin, J., Jing, Y., Wang, H., et al. (2024) · The Science of The Total Environment · doi:10.1016/j.scitotenv.2024.172391 · Cited by 19
Ennis, E. A., Wright, J., Retzlaff, C. L., McManus, O. B., Lin, Z., Huang, X., Wu, M., Li, M., Daniels, J. S., Lindsley, C. W., et al. (2015) · ACS Chemical Neuroscience · doi:10.1021/cn5001809 · Cited by 19
Yuan, M.-Y., Chen, Z.-K., Ni, J., Wang, T., Jiang, S., Dong, H., Qu, W., Huang, Z., & Li, R. (2020) · Psychopharmacology · doi:10.1007/s00213-020-05552-6 · Cited by 19
Kumar, M., Singh, S. P., & Chaturvedi, C. M. (2016) · Experimental Neurobiology · doi:10.5607/en.2016.25.6.318 · Cited by 19
Ruggiero, R. N., Rossignoli, M. T., Lopes‐Aguiar, C., Leite, J. P., Bueno-Júnior, L. S., & Romcy-Pereira, R. N. (2018) · Experimental Neurology · doi:10.1016/j.expneurol.2018.02.011 · Cited by 19
Siqueira, A. A., Cunha, A. F., Marques, G. L. M., Felippe, I. S. A., Minassa, V. S., Gramelich, T. C. D. S., Cicilini, M. A., Ferreira, T. A. A., Pires, R. G. W., Sampaio, K. N., et al. (2018) · Neurotoxicology and Teratology · doi:10.1016/j.ntt.2018.11.002 · Cited by 19
Muscarinic receptors in energy homeostasis: Physiology and pharmacology
Falk, S., Lund, C., & Clemmensen, C. (2019) · Basic & Clinical Pharmacology & Toxicology · doi:10.1111/bcpt.13311 · Cited by 18
Fasakin, O. W., Oboh, G., Ademosun, A. O., & Lawal, A. O. (2022) · Inflammopharmacology · doi:10.1007/s10787-022-01006-x · Cited by 18
Yu, N., Song, H., Chu, G., Zhan, X., Liu, B., Mu, Y., Wang, J., & Lu, Y. (2022) · Neuroscience Bulletin · doi:10.1007/s12264-022-00962-2 · Cited by 20
van Lee, L., Quah, P. L., Saw, S., Yap, F. K. P., Godfrey, K. M., Chong, Y. S., Meaney, M. J., Chen, H., & Chong, M. F. (2017) · Depression and Anxiety · doi:10.1002/da.22637 · Cited by 18
Yang, C., Han, P., Ruan, F., Zhou, T., Luo, B., Qiu, Y., Lin, Y., Lin, Z., & He, C. (2019) · Chemosphere · doi:10.1016/j.chemosphere.2019.01.006 · Cited by 18
Fassini, A., Antero, L. S., Corrêa, F. M. D. A., Joca, S. R. L., & Resstel, L. B. M. (2015) · Journal of Neuroscience Research · doi:10.1002/jnr.23537 · Cited by 18
Roberts, W., Verplaetse, T. L., Moore, K. E., Oberleitner, L., Picciotto, M. R., & McKee, S. A. (2017) · Journal of Psychopharmacology · doi:10.1177/0269881117699618 · Cited by 18
Self-citationNeurobiological effects of phospholipids in vitro: Relevance to stress-related disorders
Donoso, F., Schverer, M., Rea, K., Pusceddu, M. M., Roy, B. L., Dinan, T. G., Cryan, J. F., & Schellekens, H. (2020) · Neurobiology of Stress · doi:10.1016/j.ynstr.2020.100252 · Cited by 20
Akmese, C., Sevinc, C., Halim, S., & Ünal, G. (2023) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2023.110760 · Cited by 17
Puangmalai, N., Bhatt, N. N., Bittar, A., Jerez, C., Shchankin, N., & Kayed, R. (2023) · Progress in Neurobiology · doi:10.1016/j.pneurobio.2023.102562 · Cited by 17
Pádua-Reis, M., Aquino, N. S. S., Oliveira, V. E. D. M., Szawka, R. E., Prado, M. A. M., Prado, V. F., & Pereira, G. S. (2017) · Behavioural Brain Research · doi:10.1016/j.bbr.2017.04.049 · Cited by 17
Wan, O. W., Shin, E., Mattsson, B., Caudal, D., Svenningsson, P., & Björklund, A. (2016) · Scientific Reports · doi:10.1038/srep26285 · Cited by 17
Zhu, X., Yao, Y., Li, X., Dong, J., & Zhang, A. (2019) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2019.03.020 · Cited by 16
Su, Z., Ruan, J., Liu, X., Zheng, H., Ruan, J., Lu, Y., Cheng, B., Wu, F., Wu, J., Liu, X., et al. (2021) · Journal of Pharmacy and Pharmacology · doi:10.1093/jpp/rgaa010 · Cited by 16
Yesudhas, A., Radhakrishnan, R. K., Sukesh, A., Ravichandran, S., Manickam, N., & Kandasamy, M. (2021) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2021.06.071 · Cited by 16
Mohammed, H. S., & Khadrawy, Y. A. (2021) · Lasers in Medical Science · doi:10.1007/s10103-021-03410-1 · Cited by 16
McClure‐Begley, T. D., Esterlis, I., Stone, K. L., Lam, T. T., Grady, S. R., Colangelo, C. M., Lindstrom, J. M., Marks, M. J., & Picciotto, M. R. (2016) · eNeuro · doi:10.1523/eneuro.0166-16.2016 · Cited by 16
Self-citationMcCloskey, M. C., Young, T. J., & Anderson, S. M. (2017) · BIOS · doi:10.1893/bios-d-15-00013.1 · Cited by 16
Metadata
- Authors
- Mineur, Y. S., Obayemi, A., Wigestrand, M. B., Fote, G. M., Calarco, C. A., Li, A. M., & Picciotto, M. R.
- Affiliations
- Yale University (US)
- ORCID
- Venue
- Proceedings of the National Academy of Sciences
- Publisher
- National Academy of Sciences
- Published
- 2013-02-11
- Volume
- 110
- Issue
- 9
- Pages
- 3573-3578
- ISSN
- 0027-8424 (ISSN-L)
- 1091-6490
- PMC
- PMC3587265
- OpenAlex
- W2020386906
- Cited by
- 375
- References
- 46
- Citations by year
- 2026: 25 · 2025: 28 · 2024: 21 · 2023: 24 · 2022: 38 · 2021: 34 · 2020: 38 · 2019: 30 · 2018: 33 · 2017: 20 · 2016: 24 · 2015: 27 · 2014: 18 · 2013: 15
- FWCI
- 13.90
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Locations
- Proceedings of the National Academy of Sciences (publishedVersion)
- Europe PMC (PubMed Central) (publishedVersion)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- Funders
- National Institutes of Health (DA033945)
- National Institute of Mental Health (MH077681, R01MH077681)
- National Institute on Drug Abuse (P50DA033945, DA033945)
- National Institute of General Medical Sciences (T32GM007205)
- Topics
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Neurotransmitter Receptor Influence on Behavior
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Neuroscience and Neuropharmacology Research
- Health Sciences › Medicine › Pharmacology (medical) › Treatment of Major Depression
- Keywords
- cholinergic neurotransmission, hippocampus, acetylcholinesterase, physostigmine, anxiety-like behavior, depression-like behavior, social defeat, fluoxetine, nicotinic acetylcholine receptors, muscarinic receptors, shRNA knockdown, mood disorders
- MeSH terms
- Acetylcholinesterase, Dependovirus, Animals, Antidepressive Agents, Anxiety, Behavior, Animal, Depression, Fluoxetine, Hippocampus, Humans, Male, Mice, Inbred C57BL, Phenotype, Physostigmine, Receptors, Cholinergic, Stress, Psychological, Time Factors, Signal Transduction, Cholinergic Antagonists, Hindlimb Suspension, RNA, Small Interfering, Mice, Resilience, Psychological, Gene Knockdown Techniques, Cholinergic Neurons
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review